PDB Short entry for 3KP3 HEADER TRANSCRIPTION REGULATOR/ANTIBIOTIC 15-NOV-09 3KP3 TITLE STAPHYLOCOCCUS EPIDERMIDIS IN COMPLEX WITH AMPICILLIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTIONAL REGULATOR TCAR; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS EPIDERMIDIS RP62A; SOURCE 3 ORGANISM_TAXID: 176279; SOURCE 4 STRAIN: ATCC 35984; SOURCE 5 GENE: SERP1949, SE_1937, TCAR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET 21A KEYWDS MULTIPLE DRUG RESISTANCE, BIOFILM, TRANSCRIPTION REGULATION, DNA KEYWDS 2 BINDING, ANTIBIOTICS, DNA-BINDING, TRANSCRIPTION, TRANSCRIPTION KEYWDS 3 REGULATOR-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.M.CHANG,C.K.CHEN,A.H.WANG REVDAT 2 01-NOV-23 3KP3 1 REMARK REVDAT 1 09-JUN-10 3KP3 0 JRNL AUTH Y.M.CHANG,W.Y.JENG,T.P.KO,Y.J.YEH,C.K.CHEN,A.H.WANG JRNL TITL STRUCTURAL STUDY OF TCAR AND ITS COMPLEXES WITH MULTIPLE JRNL TITL 2 ANTIBIOTICS FROM STAPHYLOCOCCUS EPIDERMIDIS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 8617 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20421503 JRNL DOI 10.1073/PNAS.0913302107 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 5348 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 297 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 26 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2191 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 83 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM SIGMAA (A) : 0.54 REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3KP3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-NOV-09. REMARK 100 THE DEPOSITION ID IS D_1000056269. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13C1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97622 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5615 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.45300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 3KP7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NA-HEPES, PH 7.5, 8-14% PEG 4000, REMARK 280 10-13% 2-PROPANOL PRECIPITANT, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 16.58667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.17333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 24.88000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 41.46667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 8.29333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 VAL A 2 REMARK 465 ARG A 3 REMARK 465 GLU A 84 REMARK 465 LYS A 85 REMARK 465 PRO A 86 REMARK 465 ASP A 87 REMARK 465 SER A 88 REMARK 465 ASN A 89 REMARK 465 THR A 90 REMARK 465 ASP A 91 REMARK 465 GLN A 92 REMARK 465 ARG A 93 REMARK 465 LEU A 94 REMARK 465 LYS A 95 REMARK 465 MET B 1 REMARK 465 VAL B 2 REMARK 465 ARG B 3 REMARK 465 ARG B 4 REMARK 465 LYS B 85 REMARK 465 PRO B 86 REMARK 465 ASP B 87 REMARK 465 SER B 88 REMARK 465 ASN B 89 REMARK 465 THR B 90 REMARK 465 ASP B 91 REMARK 465 GLN B 92 REMARK 465 ARG B 93 REMARK 465 LEU B 94 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 50 -146.82 -163.96 REMARK 500 LEU A 52 149.45 173.93 REMARK 500 THR A 53 -155.69 -94.57 REMARK 500 ASN A 64 118.74 -22.03 REMARK 500 LYS A 98 -157.02 -130.45 REMARK 500 LEU A 99 -167.24 -105.44 REMARK 500 THR A 122 -7.75 -145.92 REMARK 500 ASP A 124 -4.85 -156.68 REMARK 500 SER A 127 -48.11 -24.53 REMARK 500 SER A 149 -19.26 -38.69 REMARK 500 GLU B 6 -14.60 -147.71 REMARK 500 ILE B 96 100.70 89.63 REMARK 500 ALA B 112 -39.10 -37.96 REMARK 500 ASP B 126 90.35 -69.52 REMARK 500 SER B 127 -26.57 -36.21 REMARK 500 LYS B 150 128.11 -39.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AIC B 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AIC B 2002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KP2 RELATED DB: PDB REMARK 900 RELATED ID: 3KP4 RELATED DB: PDB REMARK 900 RELATED ID: 3KP5 RELATED DB: PDB REMARK 900 RELATED ID: 3KP6 RELATED DB: PDB REMARK 900 RELATED ID: 3KP7 RELATED DB: PDB DBREF 3KP3 A 1 151 UNP Q5HLN6 Q5HLN6_STAEQ 1 151 DBREF 3KP3 B 1 151 UNP Q5HLN6 Q5HLN6_STAEQ 1 151 SEQRES 1 A 151 MET VAL ARG ARG ILE GLU ASP HIS ILE SER PHE LEU GLU SEQRES 2 A 151 LYS PHE ILE ASN ASP VAL ASN THR LEU THR ALA LYS LEU SEQRES 3 A 151 LEU LYS ASP LEU GLN THR GLU TYR GLY ILE SER ALA GLU SEQRES 4 A 151 GLN SER HIS VAL LEU ASN MET LEU SER ILE GLU ALA LEU SEQRES 5 A 151 THR VAL GLY GLN ILE THR GLU LYS GLN GLY VAL ASN LYS SEQRES 6 A 151 ALA ALA VAL SER ARG ARG VAL LYS LYS LEU LEU ASN ALA SEQRES 7 A 151 GLU LEU VAL LYS LEU GLU LYS PRO ASP SER ASN THR ASP SEQRES 8 A 151 GLN ARG LEU LYS ILE ILE LYS LEU SER ASN LYS GLY LYS SEQRES 9 A 151 LYS TYR ILE LYS GLU ARG LYS ALA ILE MET SER HIS ILE SEQRES 10 A 151 ALA SER ASP MET THR SER ASP PHE ASP SER LYS GLU ILE SEQRES 11 A 151 GLU LYS VAL ARG GLN VAL LEU GLU ILE ILE ASP TYR ARG SEQRES 12 A 151 ILE GLN SER TYR THR SER LYS LEU SEQRES 1 B 151 MET VAL ARG ARG ILE GLU ASP HIS ILE SER PHE LEU GLU SEQRES 2 B 151 LYS PHE ILE ASN ASP VAL ASN THR LEU THR ALA LYS LEU SEQRES 3 B 151 LEU LYS ASP LEU GLN THR GLU TYR GLY ILE SER ALA GLU SEQRES 4 B 151 GLN SER HIS VAL LEU ASN MET LEU SER ILE GLU ALA LEU SEQRES 5 B 151 THR VAL GLY GLN ILE THR GLU LYS GLN GLY VAL ASN LYS SEQRES 6 B 151 ALA ALA VAL SER ARG ARG VAL LYS LYS LEU LEU ASN ALA SEQRES 7 B 151 GLU LEU VAL LYS LEU GLU LYS PRO ASP SER ASN THR ASP SEQRES 8 B 151 GLN ARG LEU LYS ILE ILE LYS LEU SER ASN LYS GLY LYS SEQRES 9 B 151 LYS TYR ILE LYS GLU ARG LYS ALA ILE MET SER HIS ILE SEQRES 10 B 151 ALA SER ASP MET THR SER ASP PHE ASP SER LYS GLU ILE SEQRES 11 B 151 GLU LYS VAL ARG GLN VAL LEU GLU ILE ILE ASP TYR ARG SEQRES 12 B 151 ILE GLN SER TYR THR SER LYS LEU HET AIC B2001 24 HET AIC B2002 24 HETNAM AIC (2S,5R,6R)-6-{[(2R)-2-AMINO-2-PHENYLETHANOYL]AMINO}-3, HETNAM 2 AIC 3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2- HETNAM 3 AIC CARBOXYLIC ACID HETSYN AIC AMPICILLIN; D(-)-ALPHA-AMINOBENZYLPENICILLIN; 6-[D(-)- HETSYN 2 AIC ALPHA-AMINOPHENYLLACETAMIDO]PENICILLANIC ACID FORMUL 3 AIC 2(C16 H19 N3 O4 S) FORMUL 5 HOH *83(H2 O) HELIX 1 1 ILE A 5 GLY A 35 1 31 HELIX 2 2 SER A 37 MET A 46 1 10 HELIX 3 3 THR A 53 GLN A 61 1 9 HELIX 4 4 ASN A 64 ALA A 78 1 15 HELIX 5 5 SER A 100 MET A 121 1 22 HELIX 6 6 ASP A 126 SER A 149 1 24 HELIX 7 7 GLU B 6 LEU B 27 1 22 HELIX 8 8 LEU B 27 GLU B 33 1 7 HELIX 9 9 SER B 37 LEU B 47 1 11 HELIX 10 10 THR B 53 GLY B 62 1 10 HELIX 11 11 ASN B 64 ASN B 77 1 14 HELIX 12 12 SER B 100 MET B 121 1 22 HELIX 13 13 ASP B 126 LYS B 150 1 25 SHEET 1 A 2 VAL B 81 LYS B 82 0 SHEET 2 A 2 LYS B 98 LEU B 99 -1 O LYS B 98 N LYS B 82 SITE 1 AC1 11 GLU A 13 ASN B 20 THR B 23 LEU B 27 SITE 2 AC1 11 GLN B 31 ALA B 38 GLU B 39 SER B 41 SITE 3 AC1 11 HIS B 42 ASN B 45 ARG B 110 SITE 1 AC2 8 ASP A 29 GLU B 33 TYR B 34 ALA B 66 SITE 2 AC2 8 ARG B 70 LYS B 74 LYS B 105 HOH B1043 CRYST1 108.033 108.033 49.760 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009256 0.005344 0.000000 0.00000 SCALE2 0.000000 0.010688 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020096 0.00000